By Counterforce Health Team in Tavalisse (fostamatinib disodium hexahydrate) —

How to Get Tavalisse (fostamatinib) Covered by Cigna in Pennsylvania: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Tavalisse Covered by Cigna in Pennsylvania

Tavalisse (fostamatinib) requires prior authorization from Cigna for adults ≥18 with chronic ITP who've tried prior therapies. The fastest path: Have your hematologist submit a PA request through CignaforHCP.com with platelet counts <30,000/μL, documented prior therapy failures, and bleeding risk assessment. Standard approval takes 5-7 business days. If denied, Pennsylvania's new external review program overturns ~50% of appeals. Start today: Verify your Cigna plan covers specialty drugs through Accredo and gather your recent lab results.

Table of Contents

Before You Start: Coverage Verification

Confirm Your Cigna Plan Details

First, verify that Tavalisse is covered under your specific Cigna plan. Most Cigna members receive specialty medications through Accredo Specialty Pharmacy as part of Express Scripts management.

Quick verification steps:

  1. Log into your myCigna account or call member services
  2. Confirm Tavalisse is listed as Tier 4 (specialty) on your formulary
  3. Verify your plan includes specialty pharmacy benefits
  4. Note any quantity limits or step therapy requirements
Note: Cigna's National Formulary requires prior authorization for Tavalisse regardless of plan type.

Pennsylvania-Specific Considerations

Pennsylvania residents benefit from enhanced insurance protections. If your initial request is denied, you have access to the state's Independent External Review Program, which has overturned approximately 50% of appealed denials in 2024.

What You Need to Gather

Essential Documentation Checklist

Medical Records (within 30 days):

  • Complete blood count showing platelet count <30,000/μL (or <50,000/μL with bleeding risk)
  • ICD-10 diagnosis code for chronic immune thrombocytopenia
  • Documentation of bleeding episodes or risk factors

Prior Therapy Documentation:

  • Records of corticosteroid trials (prednisone, dexamethasone) with dates and outcomes
  • IVIG or anti-D immunoglobulin treatment history
  • TPO receptor agonist trials (Promacta/eltrombopag, Nplate/romiplostim)
  • Splenectomy records (if applicable)
  • Rituximab or other immunosuppressive therapy records

Prescriber Information:

  • Confirmation of hematologist involvement (board certification preferred)
  • Consultation notes if prescribed by non-hematologist
  • Treatment plan and monitoring schedule

Step-by-Step: Fastest Path to Approval

1. Hematologist Consultation (Day 1)

Your prescriber must be a hematologist or have documented hematology consultation. They'll assess your ITP severity and prior treatment failures according to Cigna's PA criteria.

2. Complete PA Form (Day 2-3)

Your doctor's office submits the prior authorization request via:

  • CignaforHCP.com provider portal (preferred)
  • Fax: Number available through provider portal
  • EviCore by Evernorth for Express Scripts/Cigna specialty drugs

3. Include Required Clinical Data (Day 3)

The submission must include:

  • Patient demographics and Cigna ID
  • Recent platelet count (<30,000/μL threshold)
  • Documented prior therapy failures
  • Bleeding risk assessment
  • Signed PA form and supporting lab results

4. Accredo Coordination (Day 4-5)

Once approved, your prescription automatically transfers to Accredo Specialty Pharmacy. They'll contact you within 24-48 hours for verification and overnight shipping.

5. Follow-Up Timeline

  • Standard approval: 5-7 business days
  • Expedited (urgent): 24-72 hours with clinical justification
  • Initial approval duration: 3 months
  • Renewal submissions: 30 days before expiration

Clinician Corner: Medical Necessity Letter

Key Elements for Approval

Diagnosis Documentation:

  • Chronic ITP (>12 months duration preferred)
  • Platelet count trends showing persistent <30,000/μL
  • Bleeding manifestations (petechiae, purpura, epistaxis)

Prior Therapy Failures: Document insufficient response or intolerance to:

  1. First-line: Corticosteroids (prednisone 0.5-2.0 mg/kg/day or dexamethasone 40 mg/day × 4 days)
  2. Second-line: TPO receptor agonists, IVIG, or splenectomy
  3. Include specific dates, doses, duration, and outcomes

Clinical Rationale:

  • Reference ASH 2019 ITP Guidelines
  • Justify Tavalisse as appropriate third-line therapy
  • Address contraindications to other treatments

Common Denial Reasons & Solutions

Denial Reason Solution Required Documentation
"Prior therapies not documented" Submit detailed treatment history Pharmacy records, infusion logs, lab results showing lack of response
"Prescriber not hematologist" Obtain hematology consultation Consultation notes, specialist recommendation letter
"Platelet count too high" Provide recent labs showing <30,000/μL CBC within 30 days, trending platelet counts
"Not medically necessary" Submit bleeding risk documentation Clinical notes describing bleeding episodes, risk factors
From our advocates: We've seen denials overturned when providers include a detailed timeline showing specific platelet counts before, during, and after each prior therapy. This creates a clear narrative of treatment-resistant ITP that supports medical necessity.

Appeals Process in Pennsylvania

Internal Appeals with Cigna

First-Level Internal Appeal:

  • Timeline: 180 days from denial notice
  • Submission: Through CignaforHCP.com provider portal
  • Required documents: Denial letter, updated medical records, peer-reviewed literature supporting use

Peer-to-Peer Review: Request a clinical discussion between your hematologist and Cigna's medical director. This often resolves denials when clinical nuances are explained directly.

Pennsylvania External Review

If internal appeals fail, Pennsylvania's Independent External Review offers a powerful second chance:

Eligibility:

  • Must complete Cigna's internal appeal process first
  • Receive Final Adverse Benefit Determination letter
  • Submit within 4 months of final denial

Timeline:

  • Standard review: 45 days from IRO assignment
  • Expedited review: 72 hours for urgent cases
  • Additional documentation: 15 days after assignment to submit supporting materials

Success Rate: Approximately 50% of external reviews result in coverage approval.

When to Escalate

Contact the Pennsylvania Insurance Department Consumer Services at 1-877-881-6388 if:

  • Cigna exceeds response timelines
  • You need help navigating the external review process
  • You suspect unfair claim handling practices

Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals. Their platform analyzes denial letters and plan policies to draft point-by-point rebuttals aligned with payer-specific requirements, helping patients get prescription drugs approved more efficiently.

Costs & Patient Assistance

Financial Support Options

Manufacturer Assistance:

  • Rigel Pharmaceuticals may offer patient support programs
  • Check the official Tavalisse website for current copay assistance

Foundation Support:

  • Patient Advocate Foundation
  • HealthWell Foundation
  • Chronic Disease Fund

Pennsylvania-Specific Resources:

  • Pennsylvania Insurance Department's Consumer Services for billing disputes
  • Pennie marketplace plans may offer different coverage options

Cost Considerations

Tavalisse costs approximately $14,000-$16,000 per 60-tablet bottle according to wholesale acquisition cost data. With Cigna coverage and Accredo dispensing, your out-of-pocket costs depend on your specific plan's specialty tier copayment structure.

FAQ: Your Top Questions Answered

How long does Cigna prior authorization take for Tavalisse in Pennsylvania? Standard PA decisions take 5-7 business days. Expedited requests (for urgent medical needs) are processed within 24-72 hours.

What if Tavalisse isn't on my Cigna formulary? Request a formulary exception through your provider. Include medical necessity documentation and evidence that preferred alternatives are inappropriate.

Can I appeal if my hematologist isn't available for peer-to-peer review? Yes. Submit a detailed medical necessity letter with clinical rationale and supporting literature. Consider having another qualified hematologist review the case.

Does step therapy apply to Tavalisse? Cigna requires documented failure of prior ITP therapies but doesn't mandate a specific sequence. Your hematologist can justify the treatment approach based on clinical circumstances.

What happens if I'm denied during Pennsylvania's external review? The IRO's decision is binding on Cigna. If approved, coverage must be provided immediately, including retroactive coverage if you paid out-of-pocket.

How often do I need to renew Tavalisse authorization? Initial approvals are typically for 3 months, with renewals up to 12 months based on documented clinical response and ongoing need.

Sources & Further Reading

Disclaimer: This guide provides general information about insurance coverage and appeals processes. It is not medical advice. Always consult with your healthcare provider about treatment decisions and work with your insurance company directly for coverage determinations. Coverage policies and procedures may vary by plan and can change over time.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.